Integrating smoking cessation and TB treatment programmes must also take into account potential drug-drug interactions between smoking cessation medications and anti-TB drugs, a critical area for patient safety and effective TB management
According to estimates from the Surveillance, Epidemiology, and End Results (SEER) Program, supported by NCI, new cases of lung cancer have decreased from a rate of 67 per 100,000 persons in 1992 to 46.1 per 100,000 in 2016
E.et al (2014)
Beyond cancer, smokeless tobacco use can lead to nicotine addiction, heart disease, and reproductive issues
Inhaling the smoke activates the THCa and delivers fast results
15, nearly 1,500 lung injury cases associated with the use of these products have been reported to the Centers for Disease Control and Prevention from across the U.S